| Type | Description |
|---|---|
| Definition | akirin 2 |
| Date | Results | Publications |
|---|---|---|
| 2020-05-16 11:48:00 | Akirin2 expression is negatively controlled by miR-490-3p in cholangiocarcinoma (CCA) cells, and miR-490-3p attenuated cell migration and angiogenesis in CCA cells by silencing Akirin2. | 30886152 |
| 2018-11-03 10:10:00 | Akirin-2 can be a novel biomarker in imatinib resistance. Targeting Akirin-2, NFkappaB and beta-catenin genes may provide an opportunity to overcome imatinib resistance in CML. | 29945498 |
| 2018-01-20 11:45:00 | this review discusses current understanding of the molecular mechanisms that have instrumental roles in governing the inflammatory response with special emphasis on Akirin2 in B cells | 28605346 |
| 2016-06-28 11:45:00 | Akirin-2 downregulation increases chemosensitivity in human glioblastomas more efficiently than Twist-1 | 26036627 |
| Type | IDs |
|---|---|
| Synonymous | C6orf166, FBI1, dJ486L4.2 |
| Gene |
UniProtKB-ID:
AKIR2_HUMAN,
Q9NW35_HUMAN
UniprotKB:
Q53H80,
Q9NW35
UniParc:
UPI000007243F,
UPI000006D634
EMBL:
AK222701,
BC003042,
BC005051,
AK001204,
BC000764,
AL133211
Ensembl:
ENSG00000135334
KO:
hsa:55122
|
| Nucleutide sequences |
EMBL-CDS:
AAH00764.1,
AAH03042.1,
BAD96421.1,
AAH05051.1,
BAA91551.1
Ensembl_TRS:
ENST00000257787
|
| Protein sequencees |
Ensembl_PRO:
ENSP00000257787
RefSeq:
NP_060534.1
|
| Others |
UniRef100:
UniRef100_Q53H80,
UniRef100_A0A2I3MDU2
UniRef90:
UniRef90_Q25C79
UniRef50:
UniRef50_Q25C79
UniGene:
Hs.485915
CCDS:
CCDS5013.1
|
| {{proteinIndex+1}} | mRNA | Protein | UniprotKB | Description | ||||
|---|---|---|---|---|---|---|---|---|
| Refseq |
{{protein.nucleotideVersion}}
Ensembl: {{protein.nucleotideEnsembl}} |
{{protein.proteinVersion}}
Ensembl: {{protein.proteinEnsembl}} |
{{uniprot}} , |
Definition: {{{protein.definition}}}Transcript Veriant:{{protein.transcriptVeriant}} Status: {{protein.status}} |
||||
| Location | {{protein.contigId}} ( {{protein.positionStart}}..{{protein.positionEnd}} , {{protein.orientation}} ) | |||||||
| Conserved domain | Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
||||
暂无数据
| 排名 | 科研单位 | 文献 |
|---|---|---|
| {{affIndex+1}} |
{{aff.value}} |
{{aff.size}} |
目前还没有研究热点单位
| 排名 | 研究人员 | 文献 |
|---|---|---|
| {{authorIndex+1}} |
{{author.value}} |
{{author.size}} |
目前还没有研究热点人员